(Q47707737)

5 February 2018

title

Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil (English)

1 reference

5 February 2018

0 references

Marzochi KB

1

1 reference

5 February 2018

Marzochi MA

2

1 reference

5 February 2018

Silva AF

3

1 reference

5 February 2018

Grativol N

4

1 reference

5 February 2018

Duarte R

5

1 reference

5 February 2018

Confort EM

6

1 reference

5 February 2018

Modabber F

7

1 reference

5 February 2018

publication date

1 March 1998

1 reference

5 February 2018

Memórias do Instituto Oswaldo Cruz

published in

1 reference

5 February 2018

volume

93

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

205-212

1 reference

5 February 2018

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

Practical progress and new drugs for changing patterns of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

Editorial: Measurement of delayed skin-test responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

Enzyme immunoassays with special reference to ELISA techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02761998000200014

10.1590/S0074-02761998000200014

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9698895

1 reference

5 February 2018